Ticker Update
Midatech Pharma (MTP) Rallies Followed by Positive Results of MTX110 Phase I DIPG Study
The company confirms Phase II Dose and encouraging survival data. Midatech Pharma Plc (MTP) was one of the leading stocks today popping up to 42% in the premarket. The stock rallied after the company announced positive headline results from its Phase 1 study in MTX110
